Comparing the current results to its competitors, Electromedical Technologies Inc reported Revenue decrease in the 3 quarter 2024 year on year by 0 %, despite the revenue increase by the most of its competitors of 5.93 %, recorded in the same quarter.
Electromedical Technologies Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 44.5 %
Electromedical Technologies Inc 's Comment on Competition and Industry Peers
The company operates in the pain management, rehabilitation, and physical therapy market, competing with medical devices, traditional treatments such as drug prescriptions, surgery, rehabilitation therapy, and complementary practices like acupuncture. Its competitors include large, diversified companies with greater financial, marketing, and distribution resources, as well as stronger name recognition. Specifically named competitors are Galvani Bioelectronics, Medtronic, DJOGlobal-Chatanooga, and IcyHot. The company has historically competed in the electromedical and bio-electrotherapy device segment, including the crowded TENS market, which now features inexpensive devices like those produced by IcyHot.
Publicly Traded Peers of Electromedical Technologies Inc
Electrocore Inc Share Performance
+88.34%
One Year
Electrocore Inc
Profile
Electrocore Inc operates on a business model that focuses on developing and commercializing innovative neuromodulation therapies. They utilize non-invasive vagus nerve stimulation (nVNS) to offer patients drug-free solutions for various medical conditions. The company's approach involves leveraging their understanding of the human body's electrochemical signaling system to provide targeted and effective treatments across multiple therapeutic areas.
Neuroone Medical Technologies Corp Share Performance
+4.52%
30 Days
Neuroone Medical Technologies Corp
Profile
Neuroone Medical Technologies Corp operates using a specific business model that focuses on delivering medical solutions or technologies related to neurological disorders or conditions.
Neuropace Inc's business model revolves around the development and commercialization of medical devices for the treatment of neurological disorders, primarily focusing on epilepsy.
NeuroMetrix Inc is a medical technology company that specializes in developing and selling wearable therapeutic devices and diagnostic products for chronic diseases and conditions. Their business model revolves around creating innovative solutions to improve patient outcomes and provide healthcare professionals with valuable insights.
Nevro Corp is a medical technology company that primarily focuses on developing and providing innovative solutions for chronic pain management. Their business model centers around the design, manufacturing, and commercialization of their proprietary spinal cord stimulation (SCS) systems. By leveraging advanced neuromodulation technology, they aim to improve the lives of patients suffering from debilitating chronic pain conditions.
Sources:
Electromedical Technologies Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Electromedical Technologies Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
